The affected product, which was distributed to wholesalers, suppliers and retailers, is being recalled after the drug didn’t meet specifications or acceptance criteria for dissolution, the company said.
“Product efficacy may be decreased due to incomplete absorption of the active ingredients,” the recall notice reads.
The affected lot number is 183222, with an expiration date of November 2020.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.